Countdown To The Allergan Merger, And More From AbbVie’s Q4 Earnings

 
• By Joseph Haas
Rockets
Sales are soaring for recent AbbVie launches like Skyrizi, Imbruvica and Venclexta

More from Earnings

More from Business